Accession Number: | 0001209191-21-038374 |
Date: | 2021-06-02 |
Issuer: | DENALI THERAPEUTICS INC. (DNLI) |
Original Submission Date: |
COLE DOUGLAS G.
C/O FLAGSHIP PIONEERING
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-02 | A | 2,074 | a | $0.00 | 5,327 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 63.76 | 2021-06-02 | deemed execution date | A | 6,222 (a) | 2031-06-02 | common stock 6,222 | $63.76 | 6,222 | direct |
ID | footnote |
---|---|
f1 | each share is represented by a restricted stock unit ("rsu") and a contingent right to receive one share of common stock of the issuer. 100% of the rsus shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the issuer's next annual meeting of stockholders occurring after the grant date. |
f2 | 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the issuer's next annual meeting of stockholders occurring after the grant date. |